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Ribonucleic  acid preparations (RNA) of four different animal viruses, isolated by 
the method of Gierer and Schramm (1  (a), (b)) have been reported to be infectious; 
in each instance the documented infectivity of the RNA was demonstrated in vi~o 
and the RNA preparations were made from tissues infected in rico. Colter eta/. have 
reported infectivity in mice, of RNA from Mengo  (2)  and West Nile  (3)  virus-in- 
fected cells (i.e. Ehflich ascites tumor) in mice and from type II poliovirus-infected 
suckling  hamster brain  (3). Wecker and Schiifer have reported comparable activity 
of RNA from Eastern equine encephalomyelitis virus-infected mouse brain (4). 
Cytopathogenic action occurred occasionally  in an unpredictable fashion in tissue 
culture infected by RNA preparations from tissues of infected animals (3, 4). Rig- 
orous proof that the changes were caused by virus RNA itself  and  not by intact 
virus was  not  available because of the  random  occurrence of the  cytopathogenic 
action. 
The present paper describes results of studies  on a  phenomenon previously 
reported  (5):  reproducible  infection  of HeLa cell  monolayers by RNA  pre- 
pared from partially purified types I and H  polioviruses grown in tissue culture. 
The type of the intact virus which is produced following invasion of the HeLa 
cells by KNA corresponds to the type of virus from which the RNA was isolated. 
The evidence presented  supports the conclusion that the RNA itself and not 
intact virus resistant to phenol, induces the infection of HeLa cells. The results 
suggest that the tissue culture system used offers a suitable tool for quantitative 
studies on the factors which influence the efficiency of the RNA infectivity and 
also for biochemical studies of RNA as a  determinant  of heritable characters 
and infectious agent. 
Materials and Methods 
Virus Source.--In all experiments reported, the source for the preparations of polio virus 
RNA was virus produced and partially purified by the Cutter Laboratories by step 1 of the 
Schwerdt-Schaffer method (6). After growing virus in either monkey kidney or human amnion 
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ceils in monolayer, Cutter Laboratories concentrated the virus 100-fold by methanol precipita- 
tion, celite adsorption, and elution. The first eluate is designated El; two subsequent ones as 
E2 and E3. E1 has a higher virus content than Fa and E~, but the latter contain less non-virai 
material. The yield from 10 liters of crude virus was received in our laboratory in 300 ml., 100 
ml. of each of the eluates, El, E2, and  E3 in 0.88 ~ NaC1 buffered with 0.04 ~, sodium PO4 
to pH 7.0 to 7.4. The Mahoney strain of virus was used for type I, and MEF-1 strain for type 
II poliovirus. 
The whole virus titer of E1 preparations of type I  virus grown in human amnion cells has 
varied from 4 X  109 to 1.1 X  101°, and in monkey kidney 5 X  109 to 1.5 X  10  l° plaque-form- 
ing units per ml.; E1 type II virus grown in amnion ceils showed a titer of 2 X  109. 
Preparation of InJectio~  RNA from Intact Poliovirus.--Infectious  RNA has been made 
from type I, E1 and E2, and type II, E1 poliovirus suspensions. 
The method described  by  Gierer and  Schramm  (1)  for isolation of RNA from tobacco 
mosaic virus was used with a slight modification for preparation of RNA from polioviruses. 
The phenol (114 gin.) is dissolved ~  28 ml. of distilled water; this solution is stored at 4°C. 
and may be used over a period of several months. To each of two 7 ml. pyrex glass centrifuge 
tubes in an ice bath, 2.5 ml. of a cold E preparation of poliovirus is delivered. The same volume 
of water-saturated phenol is added, the tubes are closed with a rubber stopper and the mix- 
tures shaken  vigorously by hand  for 8  minutes at room temperature.  The two phases are 
separated  in 30 seconds at  12,000 R.p.~s. (hlgh-speed  head of International centrifuge, tem- 
perature 0°C.). The water phase is transferred  to another pair of centrifuge tubes in an ice 
bath, each containing 2.2  ml. of water-saturated phenol. The mixture is shaken again vigor- 
ously for 4 minutes, centrifuged, and the water phase for the third time shaken with an equal 
volume of water-saturated  phenol for 4  minutes and  centrifuged. The total water phase is 
transferred to a conical 12 ml. centrifuge tube and the phenol is removed by five successive 
extractions  with an equal volume of peroxide-free ether  (fresh  Mailinckrodt).  To remove 
residual ether, nitrogen is bubbled through the solution at 0°C. for 5 minutes. The pH of the 
solution is adjusted to pH 6.8 to 7.0 with NaI-ICO3 with phenol red as the indicator. This 
preparation will be referred to in the paper as "undiluted" RNA even though there has been 
slight dilution in adjusting the pH. Modification when used will be described for each experi- 
ment. 
Mallinckrodt phenol was used for preparation of I~A for most experiments. Some chemical 
companies add  a  preservative (hypophosphorous acid)  to their phenol;  the addition is not 
always marked on the label. Phenols made by different companies have yielded from the same 
lot of E1 poliovirus RNA preparations with different degrees of infectivity. The use of phos- 
phate-buffered water for dissolving the phenol has reduced the differences  between phenols 
from different sources.  It may prove advisable to free the phenol from the preservative by 
successive washings with water or by distillation. 
Osmotic shock and dodecylsulfate treatment of poliovirus did not yield detectable amounts 
of infectious RNA. 
Cell Monolayers.--Cell monolayers prepared from HeLa populations derived from a single 
clone L-5 of Sprunt et al. (7) by the method of Puck (8), and from the human amnion cell line 
(9) were used as tools for studying infectivity of RNA preparations. After growth on a side of 
a rectangular 6 ounce bottle overlayered with 10 ml. of Puck's complete medium (8) for 6 to 7 
days, the cells were suspended by trypsinization (0.025 to 0.05 per cent trypsin), centrifuged 
for 7 to 8 minutes at approximately 1,000 R.P.K., and resuspended in complete Puck's medium. 
Approximately 1,000,000 ceUs were seeded in each Petri dish (60 mm.) and incubated for 1 to 
2 days at 35°C. in a closed container gassed with 5 per cent COs for a period sufficient to main- 
tain the pH at approximately 7.2-7.5.  A comparison of monolayers of ages varying from 17 
hours to 7 days showed no significant difference in susceptibility to infection by RNA. Prior H.  E.  ALF_,XANDER~ G.  KOCH~ I.  M.  MOUNTAIN~  O.  VAN  D,~M'~E,  495 
to seeding with the RNA, the fluid was removed from the monolayer and the cells washed 2 
times with 2 ml. of Hanks' solution minus Ca, Mg, and phosphate ions. At each washing an 
effort was made to remove the fluid completely. 
After the plates are seeded with 0.1 ml. of the RNA preparation or whole virus suspension, 
a  period of at least 20 minutes is permitted for adsorption before the agar overlay is added 
unless specified otherwise. The cultures are then incubated as before for 2 to 4 days before the 
neutral red-containing agar is added in a second overlay. Two to 5 hours after addition of the 
neutral red-containing agar cytopathogenic action is recorded. 
A gar Overlays.-- 
A. Agar overlay used after seeding of monolayer: To lactalbumin yeast medium described by 
Meinick (10), 0.25 per cent glucose and 0.3 per cent tris  1 are added. The pH is adjusted to 
7.2-7.4 with 1 ~ HC1. This basic medium is used as follows: 
Component 1. Basic medium -4- 2 per cent agar.  2 
Component  2.  Basic medium  -b  20 per cent  horse serum  and 3.5  per cent solution of 
NaHCO~) 
A 4 cc. volume of a  1 : 1 mixture of components 1 and 2 is added to each monolayer. 
B. Neutral red-containing agar overlay: For this purpose equal parts of components 1 and 2 
are used  but component 2  is modified; the horse serum  and NaHCO3  are  eliminated and 
neutral red, 1:5,000 final dilution is added. 
Enzymes.--All enzymes were dissolved in Hanks' solution minus Ca, Mg and PO4 ions. 
RNAase, crystallized, bovine origin, Armour Co., Chicago. 
DNAase,  crystalline desoxyribonuclease, Worthington Biochemical Sales  Co.,  Freehold, 
New Jersey. 
Papain, crystallized, Worthington Biochemical Sales Co. 
Chymotrypsin, crystallized, salt-free, bovine origin, Armour Co. 
Lysozyme, crystallized, prepared from egg whites, Armour Co. 
Preparation of Globulins.--Three pools of serum from rhesus monkeys, before (i.e. "normal") 
or after hyperimmunization with polioviruses type I  or II, were made. The immune monkeys 
had received repeated intramuscular injections of type I  Brunhilde or type II YSK polio- 
infected monkey spinal cord and medulla, in adjuvants (11). 
Serum from rabbits was obtained before or after repeated intravenous injection of active 
polioviruses type I or II (12). 
The globulins from monkey serum were precipitated at ~  saturation ammonium sulfate; 
the globulins were obtained from rabbit serum at  ~.~ saturation. All operations were carried 
out at 4°C. The precipitated globulins after standing overnight were recovered after centrif- 
ugation and  restored  to  original serum volume in distilled water. The cycle of precipitation 
and solution was repeated twice and after the third (final) precipitation the globulins were 
dissolved in Earle's solution. Dialysis of the globulin solutions was carried out against 25 
volumes of Earle's solution for 6 hours, and, after a change of dialyzing fluid to fresh Earle's 
solution, dialysis proceeded overnight. 
EXPERIMENTAL  RESULTS 
Most of the experiments which examined RNA and whole virus for qualita- 
tive  distinction  in  their  infectivity were performed  during  the period  when 
1 Sigma 7 to 9 buffer grade tris (hydroxymethyl) aminomethane, Sigma Chemical Co., St. 
Louis. 
Noble agar Difco (unwashed). 
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reproducible cytopathogenic action could be produced by RNA  only in  the 
undiluted form. Some of the factors now known to be responsible for failure 
to induce infection with diluted RNA will be described later. Even though the 
undiluted RNA produced so many infectious units that a  confluent sheet of 
cell destruction occurred, the effect of the test substances, ribonuclease, normal 
monkey serum, and normal and polio-immune globulins, used for demonstrating 
the qualitative difference between infectivity of isolated poliovirus RNA and 
intact virus, was virtually an all-or-none phenomenon. Therefore the experi- 
ments,  though  only  qualitative  for  the  most  part,  offer a  valid  basis  for 
comparison. In any one experiment the same RNA preparation was used in the 
presence and absence of the test substances. 
TABLE I 
Infectivity of Poliovirus RNA * in HeLa Cdl Monolayers 
No exposure to RNAase  Exposure to RNAase <1 rain. 
Experiment  No. 
Cytopathogenlc  No. of plates  Cypathogenic  No. of plates  action  action 
10 
14 
14 
10 
8 
8 
C~ 
C 
C 
C 
C 
60§ 
8 
16 
12 
10 
15 
8 
0 
0 
0 
0 
0 
0 
* RNA, Experiments 1 to 5: "undiluted" RNA from E1 poliovirus type I  grown in mon- 
key  kidney cells.  Experiment 6:  "undiluted" RNA  from Et poliovirus type II  grown in 
monkey kidney cells. 
~t C, cytopathogenic action is confluent and covers most of monolayer. 
§ Average number of plaques per plate. 
Differentiation  between Infectivity of Poliovirus RNA and Infectivity of Intact 
Vi~'~.  -- 
The effect of various test substances on the infectivity of RNA and of the intact virus from 
which it was derived, was studied by the following procedure. The RNA, or intact virus, (9 
parts) was mixed with the test substance (one part), allowed to stand at room temperature for 
a period of 1 to 10 minutes, and seeded in 0.1 ml. quantities on each of a series of washed cell 
monolayers. After a 20 to 30 minute interval at room temperature, the standard agar overlay 
was added  and  the cultures were  incubated, processed, and  observed as  described under 
Materials and Methods. 
Comparison  of Effect of Ribonuclease  on Types I  and II Poliovirus RNA and 
on  Intact  Virus.--In  Table  I  are  listed  the  results  of 6  experiments which 
examined the effect of ribonuclease on the infectivity of types I and II RNA for 
HeLa cell monolayers. A comparable series of monolayers was seeded in each 
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cytopathogenic action seen in all monolayers following seeding with undiluted 
RNA alone has been completely prevented by exposure to ribonuclease. Samples 
of agar taken from areas of cytopathogenic action produced by RNA regularly 
yielded whole virus on passage; the type corresponded to the type from which 
the  RNA  was  prepared.  Agar  from areas  of comparable size in monolayers 
seeded with the mixture of RNA and ribonuclease, in which no cytopathogenic 
action appeared, yielded no virus on passage. 
Table II shows that the same concentration of RNAase had no demonstrable 
effect on the infectivity of intact poliovirus. 
In table III are listed the results from experiments designed to determine 
the smallest concentration of ribonuclease required to prevent completely the 
TABLE II 
Effect of RNAase* on Infectivity of Intact Polio~rus Type I in Cell Monolayers 
Virus 
HeLa cell virus 
Amnion cell 
virus E1 conc. 
Experiment No.  Negative |ogto 
rival dilution 
5.5 
5.5 
6.0 
6.0 
No. of plaques/plate 
Hanks' solution 
26 
26 
RNAase 100/~g./ml. 
in Hanks' solution 
28, 
68 
26 
23 
7.5 
7.5 
7.5 
7.5 
7.5 
15, 
70 
29 
23 
29 
35 
17 
25 
13, 
23 
29 
15 
23 
15, 
33 
15 
* RNAase: Virus in contact with RNAase (or Hanks')  for 5 minutes before seeding. 
invasion of 0.1  ml. of undiluted RNA,  when the duration of exposure is less 
than  2  minutes  prior to  seeding on monolayers.  It  is  seen  that  0.1  /~g./ml. 
rapidly inactivated practically all of the infectious RNA. To insure prevention 
of infection by the undiluted RNA in all experiments, it was necessary to use a 
higher concentration.  The high  concentration used  as  a  routine  at  first for 
testing the action of ribonuclease (100 #g./ml.) was tested in the H. influemae 
transforming system and was shown not to affect the transforming activity of 
desoxyribonucleic acid (DNA) controlling streptomycin resistance (13). There- 
fore,  contamination  of  ribonuclease  by  desoxyribonuclease was  not  demon- 
strable. 
Influence of Whole Normal Serum and Normal and Polio-Immune Globulins 
on the Infectivity of RNA and of Intact Virus.--The demonstration of inactiva- 
tion of the infectivity of the RNA by normal monkey sera by Colter and his 
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culture system. Table IV shows that when the undiluted RNA is exposed to a 
1:10 dilution of either a pool of normal monkey sera or to individual monkey 
TABLE III 
Concentration of RNAase for Ra ,id Inactivation  of Infectivity o.[ RNA * in HeLa Cells 
Average No. of  Conc. RNAase  No. of plates  plaques/plate  Experiment  RNA 
1 
2 
3 
"Undiluted" 
gc 
"Undiluted" 
c¢ 
"Undiluted" 
~g./ml. 
0 
100 
10 
2 
0 
100 
10 
2 
0 
0.1 
8 
10 
Confluent 
0 
0 
0 
Confluent 
0 
0 
0 
Confluent 
1 
* RNA, undiluted RNA--Experiment 1. Grown in monkey kidney cell El poliovirus. 
Experiment 2. Grown in monkey kidney cell El poliovirus. 
Experiment  3.  Grown in amnion cell Et poliovirus. 
TABLE IV 
Effect of Normal Monkey Serum on Infectivity of Type I  PolioWrus RNA in Human Cell 
Monolayers 
RNA alone  RNA q- serum 1:10 dilution* 
Experiment No. 
No  of plates  No. of plates 
3 
5 
4 
12 
Total No.$ of 
plaques 
3,500§ 
1,000 
800 
588 
3 
5 
4 
12 
Total No. of 
plaques 
3 
0 
3 
10 
* RNA exposed to serum for 2 minutes prior to seeding. 
Total number plaques in all plates seeded. Count is based on inoculum of 0.1 ml. of 
undiluted RNA per plate. 
§ RNA diluted  1  : 10 in 1 M NaCI +  0.04 •  phosphate  and seeded in 0.1 ml. per mono- 
layer. 
sera for 2 minutes at room temperature before seeding on cell monolayers, most 
of the infectivity is inactivated. In Experiment 1,  a  total of 350 plaques were 
counted on the three monolayers, each of which was seeded with 0.1 ml. of a 
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derived from an estimate of 200 plaques on each of the 4  or 5 plates which 
showed confluent cytopathogenic action after seeding with 0.1 ml. of undiluted 
RNA. The lower plaque count produced by undiluted RNA in experiment 4 is 
not understood. 
On the premise that normal serum might contain sufficient ribonuclease to 
inactivate the infectivity of poliovirus RNA, measurements were made of the 
ribonuclease content of a number of normal monkey sera, normal and immune 
globulin samples, and a few other test substances by the method of Anfinsen 
(14).  Table V indicates that 11 individual monkey sera and one pool showed 
ribonuclease  in  concentrations  ranging  from  0.6  /zg./ml.  to  greater  than 
5/zg./ml. A single rabbit serum also showed detectable RNAase activity, but 
none was found in a  1:10 dilution of one normal horse serum, or in globulin 
from normal or polio-immune rabbit sera. 
In view of the absence of RNAase in globulin, it was possible to demonstrate 
a further difference between the quality of infectivity due to RNA, on the one 
hand, and that due to intact virus (15).  Table VI shows that intact virus is 
inactivated by globulin made from homotypic serum, but not by normal serum 
or RNAase.  Infectivity of RNA  is inactivated completely by RNAase and 
almost completely by whole normal serum, but not by globulin made from 
homotypic serum. A sample of bovine plasma albumin in 5 per cent concentra- 
tion, as well as lysozyme (100 ~g./ml.), a basic protein which is comparable in 
size of molecule to ribonuclease, has been shown not to influence the infectivity 
of either RNA or the whole virus. 
Effect of DNAase on the Infectivity of the RNA.--Schaffer and Schwerdt (16) 
have reported that crystalline poliovirus is a  nucleoprotein, and that approx- 
imately 25 to 30 per cent is RNA. Thus far the presence of DNA in very small 
amounts has not been  excluded.  It was  of interest,  therefore,  to  study the 
influence of DNAase on the RNAase-labil¢ infective component of poliovirus. 
In table VII, Experiments 1 and 2,  it is seen that when undiluted RNA was 
mixed with DNAase in a concentration of 100/zg./ml. for a 1 to 2 minute period, 
infectivity was not destroyed. The difference found in Experiment 1  is  not 
considered significant. A  quantitative measure of the effect of DNAase after 
a 5 minute exposure in Experiment 3 showed no alteration of the infectivity of 
RNA. 
Effect  of Chymotrypsin and Papain on the Infectivity  of Poliovirus  RNA.-- 
Exposure of type I poliovirus RNA to chymotrypsin and papain in a concentra- 
tion of 100/zg./ml. for a period of 1 to 2 minutes also failed to inactivate infec- 
tivity as shown in Table VIII. 
Factors which Alter the Degree of Infectivity of Poliovirus RNA for Cell Mono- 
layers.--For several months, during which ribonucleic acid preparations were 
tested for infectivity, mostly after dilution in Hanks' solution, only occasional 
plaques formed on HeLa cell monolayers, and their presence was unpredictable. 500  INFECTIVITY O!~ RIBONUCLEIC ACID ~'ROM POLIOVIRUS 
On passage, the plaque suspension produced intact virus of the type of origin 
of the infecting RNA, but it was not possible to prove that an occasional intact 
TABLE V 
Estimation  of Ribonudease  Concentrations  in  Test  Substances by Anfinsen Method Using as 
R,  rerences the Action of Known Concentrations  of Ribonuclease on Yeast Nucleic Acids 
Incuba- 
tion 
time 
25 rain. 
500 
0  400, 
.g 
200 
z  100 
tv 
500. 
O 
z_ 
t~ 
t~ 
45 rain. 
Reference  curves of action of known 
concentration  of  RNAase on  yeast 
nucleic acids 
J 
--1-''~--"1---~  ..... 
0,51  0.62 1.25 2.5  5.0  10. 
4"  RNA~se  per ml. 
400  / 
300, 
200 
100. 
Se~ 
I  I  I  :  ;  0.51 (~62 1.25 2.5  S~) 
..U~. RNAase per  rnk 
I(~ 
Test substances* 
"Nol'~al  'J sera 
Monkey 
1 
2 
3 
4 
5 
Pool A 
Monkey diluted 
6 
7 
8 
9 
10 
11 
Readings at 
260 ms. 
145 
140 
125 
83 
135 
85 
×2 
40  80 
135  270 
125  250 
840  1680 
140  280 
100  200 
RNAs~ 
esti- 
mated 
~,g./ml. 
1.4 
1.25 
1.1 
0.6 
1.2 
0.6 
0.45 
2.5 
2.1 
>5. 
2.7 
1.3 
Rabbit 1  400  4.2 
"  globulin  0  <0.3 
Horse ~o  0  <0.3 
Hanks' solution  0  < 0.3 
* Test System:  Incubation time at 25°C. 
25 rain.  45 rain. 
Yeast nucleic acid:  0.5 ml. 3.2%  0.33 ml. 0.8% 
Test substance:  0.75 ml.  0.5 ml. 
Uranyl acetate:  0.25 ml.  0.38 ml. 
virus particle could not have survived the phenol action because of the random 
occurrence of cytopathogenic action. The results of experiments which explored 
the cause of the low degree of infectivity of the RNA preparation when diluted 
in physiologic solutions show  that  the ionic strength  of the diluent plays an 
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The poliovirus suspension used for the preparation  of  the  RNA  is  0.88  M 
with  respect to NaCI.  After three extractions with  equal amounts  of water- 
saturated phenol, the water phase is approximately 0.5  M with respect to NaC1. 
TABLE VI 
Effect  of Test Substances  on Infectivity of Type II Intact Poliovirus  or RNA  Isolated from 
Type II F., Amnion Cell Poliovirus 
Test substance (0.1  ml.) mixed with intact  virus  or RNA  (0.9  ml.);  0.1 ml. of  mixture per plate 
!  Average  No. plaques/plate 
Ex- 
peri- 
ment 
Virus or RNA  No. of  plates 
Intact virus  6 amnion 
10-6.6 
RNA  4 amnion 
RNA  4 HeLa 
RNA  6 amnion 
R_NAase 
lOOO 
62 
0 
0 
[ Normal 
monkey 
serlHn 
undiluted 
68 
10 
0.8 
Monkey globulin 
undiluted 
Anti-I  Anti-II  Normal 
55  0  57 
C*  C  C 
C  C  C 
61  61  65 
Lysozyme 
1000 
pg./ml. 
BSS 
65 
C 
Albumin 
bovine 
plasma 
s %g /smL 
58 
C 
C 
* C, confluent. 
TABLE VII 
Influence  of DNAace on Infectivity of Type I  Poliovirus RNA* in HeLa Cells 
Average No. of  Experiment  RNA dilution  Cone. DNAase  No. of plates  plaques/plate 
"Undiluted" 
"Undiluted" 
c~ 
1:50~ 
zg./n.. 
0 
100 
0 
100 
0 
100 
Confluent 
60 
Confluent 
Confluent 
68 
95 
* RNA, preparation source: Experiment  1.  El  monkey kidney cell poliovirus,  type I. 
Experiments 2  and  3.  Ex  amrdon  cell poliovirus,  type  I. 
:~ 1:50 dilution in 0.9 M NaC1 q- 0.04 •  PO4. 
The RNA preparations produce confluent cytopathogenic action when  tested 
at this stage; when  diluted only slightly (1:4)  in one  of the physiologic salt 
solutions, the infectivity is greatly decreased. On the other hand, after a  1:10 
dilution of the RNA in hypertonic salt solutions, a  high degree of infectivity, 
usually  confluent  cytopathogenic  action,  is  maintained.  Preliminary experi- 
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by RNA show  that the highest degree of infectivity attainable at present, is 
obtained when the RNA is diluted in the following solution: 1  M NaC1 solution 
buffered with 0.04 M sodium phosphate at pH 7.2. Table IX lists the results 
of such an experiment. The interpretation of the other results must await addi- 
tional studies now in progress. There is a suggestion that some divalent cations 
TABLE VIII 
Influence of Proteolyti¢ Enzymes on Infectidty of Type I Poliovirus RNA* in 
HeLa Cells 
Enzyme  No. of plates  Cytopathogenlc  action 
Chymotrypsin, 100/zg./ml ................  7  Confluent 
Papain, 100/zg./ml ......................  7  Confluent 
None ..................................  8  Confluent 
RNAase, 100 #g./ml  .....................  8  0 
* RNA, from Et Type I poliovirus grown in monkey kidney cells. 
TABLE IX 
Influence of Different Salt Environments on Infectivity of RNA * in Human Cells in 
Monolayers 
Diluent 
1.  1 M  NaC1 +  NaHCOa ........................ 
2.  1 ~ NaC1 +  0.04 M phosphate ................. 
3.  1 ,~ NaCI +  0.04 ~ phosphate ................. 
+  8 per cent sucrose  ................. 
4. 7X  conc.  Hanks' solution +  3% sucrose 
minus Ca, Mg, and PO4 ions ................... 
S.  1  : 1 of diluents 3 +  4 ......................... 
6.  Diluent 3 +  Mg +  Ca ions§ ................... 
7.  1 : 1 of diluents 4 +  6 ......................... 
Dilution 
1:10  3 
1:10  3 
1:10  3 
1:100  3 
1:10  3 
1:10  3 
1:10  3 
1:10  3 
No. of 
plates 
Average No. 
plaques/plate 
27  (9--47):1: 
Confluent 
Confluent 
8  (2-17) 
7  (0-15) 
16  (s-3s) 
18  (7-26) 
6  (5--6) 
* RNA from amnion Ex type I virus. 
Numbers in parentheses show variation in plaques/plate. 
§ As in Hanks' solution concentrated 10-fold. 
inhibit the induction of plaque formation by the RNA and that certain anions 
like phosphate enhance the reaction. 
Recent experiments to  be reported  in a  separate paper  (18)  show  that  in 
appropriate environments the degree of infectivity of the RNA is proportional 
to the dilution factor. Fig. 1 shows the correlation between dilution factor and 
plaque counts obtained in one of these experiments. 
Time Required for Invasion of Cells by RNA.--Invasion  of some cells in the 
monolayers by poliovims RNA  occurs  shortly after  contact.  In Table X  is 
seen the relationship of duration of exposure of cells to RNA, before the agar 
overlay is added, to the degree of infectivity of the RNA. When this period is H.  E.  ALEXANDER, G. KOCH, I.  M.  MOUNTAIN, O.  VAN DAM'MIE 
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FIG. 1. Correlation of degree of infectivity of poliovirus RNA to dilution factor 
TABLE X 
Rdation of Time of Exposure* to "Undiluted"  RNA ~ and Degree of Infectivity 
in tteLa Cdl Monolayers 
503 
Average No.  Experiment  Exposure time  No. of plates  plaques/plate 
1  30 see. 
lmin. 
2  ~c 
3  ~ 
5  " 
7  " 
15  " 
2min. 
4  ~c 
6  ~ 
8  " 
10  " 
20  " 
30  " 
4 
5 
21 
29 
27 
63 
Confluent 
13 
26 
17 
Confluent 
,c 
c¢ 
* Time of exposure, interval between seeding of  RNA on monolayer and addition of 
agar overlay. 
~t RNA, from E1 type I poliovirus grown in monkey kidney cells. 
varied from 30 seconds to 30 minutes, it is seen that some cytopathogenic action 
occurs when a  30 second period of contact is allowed, but that the maximum 
degree  recognizable tinder these  conditions occurred  later,  approximately 10 
to  20  minutes after  seeding.  When the  agar  overlay is  applied  earlier than 
approximately 10 to 20 minutes after seeding of the RNA, some of the poten- 504  IN'FECTIVIT¥ O1  ~  RIBONUCLEIC  ACID  FROM  POLIOVIRUS 
tially infectious RNA is prevented from invading the cells. Whether this is a 
temperature, ribonuclease, or only a  dilution effect is under investigation at 
present. 
DISCUSSION 
Ribonucleic acid prepared by the method of Gierer and Schramm from con- 
centrated and partially purified poliovirus types I  and II has induced repro- 
ducible cytopathogenic action on HeLa and human anmion cell monolayers, 
yielding intact virus of the type from which the RNA was isolated. 
The experimental evidence suggests that it is  the poliovirus RNA,  itself, 
and not intact virus particles surviving the phenol action, which is responsible 
for the cytopathogenic action in cell monolayers. Comparison of the effect of 
RNAase, whole normal serum, normal and immune globulin on the infectivity 
of RNA and of intact virus, shows that the infectious agent in the RNA prepa- 
ration does not exhibit traits of intact virus.  Crystalline RNAase and whole 
serum,  (presumably because  of  the  RNAase  content),  have  been  shown  to 
destroy the infectivity of RNA, yet show no effect on intact virus. Immune 
globulin which  can  completely neutralize  whole virus  does  not  reduce  the 
infectivity of RNA preparations. It would seem, therefore, that the virus RNA 
is the essential infectious agent. 
The RNAase used in the experiments reported has been demonstrated to 
be free of DNAase by showing that it had no inactivating effect on the DNA 
or  transforming  principle  which  induced  resistance  to  streptomycin  in  H. 
influenzae. Moreover, DNAase in a concentration of 100 gg./ml, did not reduce 
the infectivity of poliovirus RNA.  The possibility that  a  trace  of DNA  in 
purified poliovirus can play the role of a heredity determinant would seem to 
be excluded. 
Two proteolytic enzymes, chymotrypsin and papain, failed also to inactivate 
the infectivity of poliovirus RNA. This would suggest that viral protein is not 
needed for induction of the cytopathogenic action in cell monolayers. 
Since the concentration of RNA in our preparations was only about 20 to 
30/,g./ml., it is not possible at present to prove that the protein content was 
as low  as in comparable material from tobacco mosaic virus.  However, our 
RNA  preparations  showed  a  characteristic  ultraviolet  spectrum. 
The degree of infectivity has been shown to be greatly decreased when RNA 
was diluted in physiologic solutions and to be best maintained by hypertonic 
salt solutions (1 M NaC1 and 0.04 M phosphate to pH  7.2).  The data suggest 
that some divalent cations inhibit the induction of plaque formation by the 
RNA and that certain anions like phosphate enhance the reaction. When RNA 
was stored in this solution at --70°C. its infectivity remained for 6 to 8 weeks. 
Recent experiments to be reported show that in appropriate environments 
the infectivity of the RNA is almost 1 per cent of the infectivity of the intact H.  E.  ALEXANDER~  G.  KOCH,  I.  M.  MOUNTAIN,  O.  VAN  DAMME  ~05 
virus  from which it is prepared.  The  degree  of infectivity is proportional  to 
the  dilution  of the RNA. 
Following the invasion of HeLa cells with poliovirus RNA, the cell is directed 
not only to the replication of the new and specific RNA, but is also induced to 
produce a new protein needed for elaboration of the intact virus of the specific 
type from which the RNA had been prepared. These events suggest an analogy 
with those which follow the invasion of bacteria by DNA, injected by a  bac- 
terial virus; the same DNA may play the role of an infectious agent or that  of 
an  heredity  determinant. 
SUMMARY 
Ribonucleic  acid  prepared by the method of Gierer  and Schramm from con- 
centrated  and partially  purified  types I and H  polioviruses  has been demon- 
strated  to bc infectious  for I-IcLa  and human amnion cells  in monolayers. In 
areas  of  cytopathogenic  action  resulting  from invasion  of  cells  by RNA, intact 
poliovirus,  of the type from which the RNA  had been prepared,  is present. 
The h~ectivity  of the RNA  was completely  inactivated  by a 2 minute ex- 
posure to purified  ribonuclease  or to whole normal monkey serum shown to 
contain  measurable concentrations  of  this  enzyme. Whole virus  infectivity  was 
not influenced  by RNAase or  whole normal monkey serum.  Normal and polio- 
immune  globulin,  desoxyribonuclease,  lysozyme, proteolytic  enzymes,  and 
bovine albumin failed  to inactivate  the infectivity  of RNA. 
The degree  of  infectivity  of  isolated  RNA  from poliovirus  for  cells  in  mono- 
layer  was greatly  influenced  by the  ionic  strength  of  the  cnviroument. 
The experimental evidence suggests  that isolated  poliovirus  RNA  is the 
carrier  of  the  biological  activity  responsible  for  infection  of  cells  and for  trans- 
mission  of genetic  information  which controls  type specificity. 
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